UCL spinouts recognised as leaders in London’s Life Sciences boom

UCL spinouts have taken centre stage in the ‘London Life Sciences Companies to Watch’ report, published by MedCity.

The report ranks the most exciting, innovative and fast-growing life sciences businesses spun out from the capital’s universities.

Spinouts established by UCL academics with the help and support of UCL Ventures feature prominently.

The following UCL Ventures spinouts were selected for their groundbreaking science, visionary founding teams, and impressive growth metrics:

• Autolus: https://www.autolus.com/about-us/
• MeiraGTx: http://www.meiragtx.com/
• Orchard Therapeutics: https://orchard-tx.uk/
• Quell Therapeutics: https://www.quell-tx.com/
• Glialign: https://www.UCL Ventures.com/portfolio/our-spinouts/glialign/
• Medisieve: https://medisieve.com/
• Axovia Therapeutics: https://axoviatherapeutics.com/
• Echopoint: http://www.echopointmedical.com/
• Apollo Therapeutics: https://www.apollotx.com/about-us/
• EpilepsyGTX: https://www.epilepsygtx.com/
• Spur Tx: https://spurtherapeutics.com/our-company/
• ViaNautis: https://vianautis.com/

London Life Sciences Week is expected to attract more than a thousand investors to over 70 events across the city from 16–21 November.